Allogene Therapeutics Appoints Susan Lundeen as Chief People Officer
Go back to Allogene Therapeutics Appoints Susan Lundeen as Chief People Officer| (NASDAQ: ALLO) | Delayed: 2.17 +0.14 (6.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.03 | 52 Week High | $ | |||
| Open | $2.05 | 52 Week Low | $ | |||
| Day High | $2.21 | P/E | N/A | |||
| Day Low | $2.05 | EPS | $ | |||
| Volume | 6,156,598 | |||||
